Related Experiment Video
Updated: Jun 9, 2026
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Bilateral repetitive transcranial magnetic stimulation modulates the hemispheric imbalance in major depressive
Yaqun Chen1, Li Wan1,2,3, Shuqi He1
1Affiliated Psychological Hospital Anhui Medical University Anhui Mental Health Center Hefei Fourth People's Hospital Hefei Anhui China.
Background:
Major depressive disorder (MDD) is characterised by interhemispheric functional imbalance, yet the neuromodulatory mechanisms underlying its correction remain poorly understood. Repetitive transcranial magnetic stimulation (rTMS) has shown promise in restoring hemispheric balance, but evidence regarding its effects on alpha-band functional connectivity (FC) is limited.
Aims:
This randomised, two-arm controlled trial aims to elucidate the neural mechanisms by which bilateral rTMS ameliorates interhemispheric functional imbalance in patients with MDD by reducing alpha-band functional hyperconnectivity in the left hemisphere.
Methods:
Fifty-two patients with MDD were randomised to active (n = 31) or sham (n = 21) bilateral rTMS targeting the dorsolateral prefrontal cortex (dlPFC). Active stimulation involved 20 Hz over the left dlPFC and 1 Hz over the right dlPFC. Participants underwent emotional attention network task testing with simultaneous electroencephalography recording before and after 10 sessions of rTMS. Phase slope index (PSI) was used to quantify directional FC in the alpha band (8-13 Hz). Clinical symptoms and behavioural performance were also assessed.
Results:
Active rTMS significantly improved sleep quality (PSQI, F = 5.52, p = 0.023) and reduced reaction times under both congruent and incongruent emotional conditions (-in-: t = -2.23, p = 0.031, +in-: t = -2.01, p = 0.05). Alpha-band FC analysis revealed decreased left hemispheric hyperconnectivity in the active group, particularly in the occipital, left temporoparietal and left frontocentral regions (t ranging from 2.42 to 3.65, all p = 0.038). The sham group showed placebo-driven improvements in subjective mood but no significant FC changes.
Conclusions:
Bilateral rTMS modulates interhemispheric imbalance in patients with MDD by reducing pathological alpha-band FC in left hemispheric regions, which is correlated with improved emotional processing and attentional performance. These findings support the use of alpha-band FC as a biomarker for rTMS efficacy and highlight the potential of network-targeted stimulation protocols for the individualised treatment of MDD.
